Comprehensive Phenotyping of Immune Cell Subsets

ABL scientists successfully conducted this standardized testing on a large cohort of clinical samples over 3 years, generating up to 350 data points per patient sample and providing a deep and comprehensive narrative on the modulation of the immune system by this investigational monoclonal antibody.